The impact of pre-existing immunity on the emergence of within-host immune-escape mutations in Omicron lineages
Author | Ahmed, Muna N. |
Author | Habib, Ummay Salma Abu |
Author | Abdallah, Abdallah M. |
Author | Emara, Mohamed M. |
Author | Pain, Arnab |
Author | Althani, Asmaa A. |
Author | Nasrallah, Gheyath K. |
Author | Yassine, Hadi M. |
Author | Al-Khatib, Hebah A. |
Available date | 2025-06-12T06:15:45Z |
Publication Date | 2025-01-01 |
Publication Name | Journal of General Virology |
Identifier | http://dx.doi.org/10.1099/jgv.0.002108 |
Citation | Ahmed, M. N., Abu Habib, U. S., Abdallah, A. M., Emara, M. M., Pain, A., Althani, A. A., ... & Al-Khatib, H. A. (2025). The impact of pre-existing immunity on the emergence of within-host immune-escape mutations in Omicron lineages. Journal of General Virology, 106(5), 002108. |
ISSN | 00221317 |
Abstract | The Omicron variant of SARS-CoV-2 circulating amongst highly immunized populations is anticipated to induce immunological pressures, potentially compromising existing immunity. This study investigates vaccine-induced immunity’s impact on within-host diversity of Omicron variants and evaluates sub-consensus mutations at spike protein antigenic sites. Next-generation sequencing assessed the within-host diversity of 728 Omicron-positive samples (421 vaccinated; 307 unvaccinated). Quantitative analysis revealed limited vaccine impact, regardless of lineage, vaccine type or doses. Non-lineage mutations (39, 33 and 25 in BA.2*, BA.4* and BA.5* lineages, respectively) were detected, some showing higher incidence in vaccinated individuals. Six mutations detected at sub-consensus levels at antigenic sites suggest increased immune pressure on the spike protein in vaccinated individuals. Four high-prevalence antigenic mutations, absent from global GISAID sequences, were identified. Although within-host diversity did not significantly differ between vaccination statuses, detected mutations suggest that vaccine-induced immunity may influence within-host mutation patterns. |
Sponsor | This study was approved by the Institutional Review Boards (IRBs) of Hamad Medical Corporation (HMC; MRC-01-20-145) and Qatar University (QU; 1736-EA/22). Samples were collected from patients presenting with COVID-19-like symptoms at the emergency department of Hamad Medical Corporation. Informed consent was obtained from all participants prior to sample collection, and participants were fully informed about the study’s purpose and procedures. To ensure patient confidentiality and privacy, all collected samples and associated metadata were anonymized before being transferred to Qatar University for analysis. |
Language | en |
Publisher | Microbiology Society |
Subject | immune pressure quasispecies SARS-CoV-2 vaccination virus evolution |
Type | Article |
Issue Number | 5 |
Volume Number | 106 |
ESSN | 1465-2099 |
Files in this item
This item appears in the following Collection(s)
-
Biomedical Research Center Research [805 items ]
-
Biomedical Sciences [829 items ]
-
Medicine Research [1804 items ]